Table 1.
Characteristic | Non-diabetic subjects | Patients with newly diagnosed type 2 diabetes | Patients with type 2 diabetes receiving treatment |
---|---|---|---|
N |
242 |
89 |
75 |
(FHD −/+) |
(178/64) |
(26/63) |
(12/63) |
Age (years) |
58 (57–58) |
58 (57–59) |
59 (58–60) |
BMI (kg/m2) |
26.1 (25.9–26.3) |
29.3 (28.4–30.3)*** |
30.5 (29.4–31.5)*** |
WC (cm) |
93.2 (92.4–94.0) |
101.8 (99.4–104.3)*** |
103.7 (101.2–106.2)*** |
Glucose (mmol/L) |
5.0 (4.9–5.1) |
7.6 (7.1–8.1)*** |
8.3 (8.1–9.0)*** |
Insulin (pmol/L) |
96.7 (91.9–101.8) |
166.1 (150.0–157.8)*** |
160.0 (140.0–181.8)*** |
SBP (mmHg) |
135 (134–138) |
145 (141–149)*** |
145 (141–149)*** |
DBP (mmHg) |
83 (82–84) |
88 (86–90)*** |
87 (85–89)* |
IGF-I (ug/L) | 171 (162–180) | 162 (151–172) | 156(147–166) |
BMI, body mass index; WC, waist circumference; DBP, diastolic blood pressure; FHD, family history of diabetes; IGF, insulin-like growth factor; SBP, systolic blood pressure.
P values: * < 0.05, ** < 0.01 and *** < 0.001.